FY2025 · period end Dec '25 · from the 10-K filed Feb 17, 2026
Data as filed with the SEC, provided for information only — not investment advice.
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $21.31B | $20.68B | $20.56B | $19.17B | $19.48B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $3.51B | $5.96B | $2.51B | $2.33B | $2.87B |
| Net Income | — | — | — | — | — |
| EPS (Diluted) | $15.49 | $32.70 | $5.71 | $3.79 | $8.42 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $29.68B | $28.94B | $28.31B | $27.16B | $27.58B |
| Total Liabilities | $20.70B | $20.39B | $22.80B | $22.55B | $23.32B |
| Stockholders' Equity | $6.02B | $5.82B | $3.12B | $2.46B | $2.05B |
| Cash & Equivalents | $2.88B | $3.02B | $1.23B | $0.86B | $2.36B |
| Total Debt | $13.09B | $13.08B | $14.88B | $14.93B | $15.51B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $3.54B | $2.05B | $2.37B | $1.08B | $1.57B |
| Capital Expenditures | $1.01B | $0.93B | $0.75B | $0.76B | $0.66B |
| Free Cash Flow | $2.53B | $1.12B | $1.62B | $0.32B | $0.91B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | 0.2% | 0.3% | 0.1% | 0.1% | 14.7% |
| Net Margin | negative: -0.0% | negative: -0.1% | negative: -0.0% | negative: -0.0% | — |
| Return on Equity | negative: -8.0% | negative: -26.3% | negative: -9.9% | negative: -13.1% | — |
| Return on Assets | negative: -1.6% | negative: -4.1% | negative: -1.0% | negative: -1.1% | — |
| Debt / Equity | 2.20× | 2.25× | 4.77× | 6.07× | 7.55× |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or full history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001193125-26-397901 | Sep 22, 2026 | Sep 22, 2026 | Sep 22, 2026 20:06 UTC | EDGAR |
| 8-K | 0000070318-26-000040 | Sep 8, 2026 | Sep 8, 2026 | Sep 8, 2026 21:01 UTC | EDGAR |
| 10-Q | 0000070318-26-000037 | Jun 30, 2026 | Jul 29, 2026 | Jul 29, 2026 20:27 UTC | EDGAR |
| 8-K | 0000070318-26-000032 | Jul 23, 2026 | Jul 23, 2026 | Jul 23, 2026 20:07 UTC | EDGAR |
| 8-K | 0000070318-26-000028 | May 27, 2026 | May 29, 2026 | May 29, 2026 20:05 UTC | EDGAR |
| 10-Q | 0000070318-26-000026 | Mar 31, 2026 | Apr 30, 2026 | Apr 30, 2026 20:02 UTC | EDGAR |
| 8-K | 0000070318-26-000023 | Apr 30, 2026 | Apr 30, 2026 | Apr 30, 2026 10:47 UTC | EDGAR |
| 8-K | 0000070318-26-000019 | Apr 9, 2026 | Apr 10, 2026 | Apr 10, 2026 21:00 UTC | EDGAR |
Direct links to SEC EDGAR. THC has additional filings available on the SEC site.
6 numbers TENET HEALTHCARE CORP later changed — same XBRL tag, both filings linked.
INCOME-PRETAX·Q1 1997
Major restatementwas$77M
Revised up in a 10-Q/A.
TOTAL-REVENUES·FY 1995
Major restatementwas$3.3B
Revised up in a 10-K405. Any P/S built on the original was 35.7% too high.
NET-INCOME·FY 1995
Major restatementwas$165M
Revised up in a 10-K405. Any P/E built on the original was 30.1% too high.
TOTAL-REVENUES·Q2 1996
Major restatementwas$2.9B
Revised up in a 10-Q. Any P/S built on the original was 28.9% too high.
TOTAL-REVENUES·FY 1996
Major restatementwas$5.6B
Revised up in a 10-K405. Any P/S built on the original was 27.9% too high.
TOTAL-REVENUES·Q1 1996
Major restatementwas$1.4B
Revised up in a 10-Q. Any P/S built on the original was 27.7% too high.
THC is not the only one.
See every restatement we've found across the market — or get an alert the next time THC revises a number.
Restatements are detected by comparing every vintage of a fact across all of TENET HEALTHCARE CORP's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows THC's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling TENET HEALTHCARE CORP — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on THC yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on THC and publish the result to your public profile.
Ask about TENET HEALTHCARE CORP
Continue in Workspace — cited answers on THC, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate, with delisted companies kept in.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs